postmenopausal

Here is a normal uterus with fallopian tubes and ovaries from an older postmenopausal woman.

图示:一绝经女性正常的子宫、输卵管及卵巢.

Conclusions The polymorphism of CTR gene was associated with BMD in postmenopausal women.

结论CTR基因多态性 与绝经后妇女BMD存在一定的关联.

Objective To analyze the CT appearance of centrum compression in postmenopausal patients with primary spinal osteoporosis.

目的:分析绝经后脊柱原发性骨质疏松椎体压缩的CT表现.

Results The average age of postmenopausal group was ( 60.40±10.07 ) ; and ( 48.40±5.40 ) in premenopausal group.

结果绝经组平均发病年龄 ( 60.40±10.07 ) 岁,未绝经组平均发病年龄 ( 48.40±5.40 ) 岁.

The combination drug was as an alternative treatment to classic estrogen replacement therapy in postmenopausal women.

该复方药主要用作绝经后妇女的经典的雌激素替代疗法的选择性治疗.

To explore the therapeutic effect and mechanism of Jiangu granule ( JGG ) on postmenopausal osteoporosis.

目的探索健骨 冲剂 对绝经后骨质疏松症疗效的作用机制.

Tamoxifen improves bone density in postmenopausal women, and there is some evidence of fracture reduction.

三苯氧胺改善绝经后妇女的骨密度, 并可减少骨折的发生.

Objective: Investigating the relation between the age, duration of menopause and pathologic type Postmenopausal uterus bleeding.

目的: 探讨绝经后子宫出血的年龄, 绝经年限与病理类型的关系.

Postmenopausal osteoporosis ( PMOF ) is the common disease, frequently-occurring disease after menopause.

绝经后骨质疏松症 ( PMOP ) 是绝经后妇女常见病 、 多发病.

Helps to alleviate premenstrual syndrome, menopausal symptoms and postmenopausal syndromes.

缓解经前综合症 、 更年期综合症及绝经综合症.

Multiple regression analysis showed that CTR genotypes were associated with FN BMD in postmenopausal women ( P < 0.05 ).

多元逐步回归分析提示,CTR基因型与绝经后妇女股骨颈BMD相关 ( P<0.05 ).

Women who have completed childbearing or are postmenopausal would be the most appropriate candidates for UFE.

不再生育的或者经绝后的妇女是最适合接受子宫纤维瘤栓塞治疗的人选.

AIM : To observe the clinical effects of alfacalcidol the treatment of postmenopausal osteoporosis.

目的: 观察阿法骨化醇治疗绝经后骨质疏松症的疗效.

Women who are menopausal or postmenopausal produce less estrogen and that leads to bone loss.

更年期和绝经后的妇女雌激素逐渐减少,这会导致骨质流失.

Postmenopausal women with uterus in situ receiv-ing unopposed estrogen replacement therapy.

有子宫的绝经后妇女接受单独雌激素替代治疗.